Inventor · disambiguated record
Sebastian Stark
Also filed as: STARK SEBASTIAN
4 granted patents·12 pending applications·7 citations·filing 2013–2025
64Inventor score
Files withASCENDIS PHARMA AS9ASCENDIS PHARMA ONCOLOGY DIV A/S5ASCENDIS PHARMA OPHTHALMOLOGY DIV A/S2
Top patents by PatentIndex Score
16 records- 0179US11642415B2Hydrogel cross-linked hyaluronic acid prodrug compositions and methodsASCENDIS PHARMA AS·Filed 2019·Granted May 9, 2023·1 cites·28 claims
- 0274US12246070B2Hydrogel cross-linked hyaluronic acid prodrug compositions and methodsASCENDIS PHARMA AS·Filed 2023·Granted Mar 11, 2025·0 cites·4 claims
- 0373US10519226B2VEGF neutralizing prodrugs for the treatment of ocular conditionsASCENDIS PHARMA OPHTHALMOLOGY DIV A/S·Filed 2013·Granted Dec 31, 2019·6 cites·21 claims
- 0463US2025255973A1Hydrogel cross-linked hyaluronic acid prodrug compositions and methodsASCENDIS PHARMA AS·Filed 2025·Application pending·0 cites
- 0561US10040850B2Protecting group comprising a purification tagASCENDIS PHARMA AS·Filed 2014·Granted Aug 7, 2018·0 cites·14 claims
- 0658US2025387508A1Methods of producing hydrogel microspheresASCENDIS PHARMA AS·Filed 2025·Application pending·0 cites
- 0752US2023241217A1Hydrogel irradiationASCENDIS PHARMA AS·Filed 2021·Application pending·0 cites
- 0850US2021330798A1Treatment of infectionsASCENDIS PHARMA AS·Filed 2019·Application pending·0 cites
- 0950US2018312582A1Protecting Group Comprising a Purification TagASCENDIS PHARMA AS·Filed 2018·Application pending·0 cites
- 1049US2021330807A1Novel hydrogel conjugatesASCENDIS PHARMA AS·Filed 2019·Application pending·0 cites
- 1149US2025387503A1Drug conjugates for the treatment of ocular disordersASCENDIS PHARMA OPHTHALMOLOGY DIV A/S·Filed 2025·Application pending·0 cites
- 1245US2022054476A1Sustained local drug levels for innate immune agonistsASCENDIS PHARMA ONCOLOGY DIV A/S·Filed 2020·Application pending·0 cites
- 1345US2022054478A1Minimization of systemic inflammationASCENDIS PHARMA ONCOLOGY DIV A/S·Filed 2020·Application pending·0 cites
- 1445US2022054477A1Induction of sustained local inflammationASCENDIS PHARMA ONCOLOGY DIV A/S·Filed 2020·Application pending·0 cites
- 1542US2022062273A1Conjugates of pattern recognition receptor agonistsASCENDIS PHARMA ONCOLOGY DIV A/S·Filed 2020·Application pending·0 cites
- 1640US2022305136A1Anti-ctla4 conjugatesASCENDIS PHARMA ONCOLOGY DIV A/S·Filed 2020·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Sebastian Stark files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →